The cannabinoid receptor gene (CNR1) is not affected in German i.v. drug users.
- Authors
- Heller, D.; Schneider, U.; Seifert, J.; Cimander, K. F.; Stuhrmann, M.
- Year
- 2001
- Journal
- Addiction biology
- PMID
- 11341859
- DOI
- 10.1080/13556210020040271
The aim of the study was to investigate a possible contribution of the cannabinoid receptor gene (CNR1) to the development of i.v. drug addiction. Allele and genotype frequencies of a previously associated flanking triplet repeat polymorphism were compared between patients and controls, and the whole coding region of the CNR1 gene of all patients were screened for presence of mutations. The study took place at the Addiction Treatment Unit of the Medical School Hannover, and two outpatients' departments in Hannover, Germany. Forty German unrelated opioid addicts (27 males and 13 females; mean age 37.9 years; range 16-53 years), took part, all of them satisfying ICD-10 and DSM-IV diagnostic criteria for opioid dependence and 81 age- and sex-matched controls (German blood donors). Measurements used were lengths of alleles, genotyping and single strand conformation polymorphism (SSCP) analysis. Neither the >/= 5 alleles of the extragenic triplet repeat (AAT) marker nor the alleles of an intragenic biallelic CNR1 polymorphism (1359G/A) were associated with i.v. drug use in our study group. In addition, we did not detect any sequence variation within the CNR1 gene which could confer susceptibility to i.v. drug abuse. In contrast to previous investigations, we found no evidence for an involvement of the CNR1 gene in i.v. drug addiction.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Correlations of the <i>CNR1</i> Gene with Personality Traits in Women with Alcohol Use Disorder. | Maciocha F et al. | — | 2024 | → |
| Cannabis Pharmacogenomics: A Path to Personalized Medicine. | Babayeva M et al. | — | 2023 | → |
| The genetic aetiology of cannabis use: from twin models to genome-wide association studies and beyond. | Verweij KJH et al. | — | 2022 | → |
| Associations of CB1 cannabinoid receptor (CNR1) gene polymorphisms with risk for alcohol dependence: Evidence from meta-analyses of genetic and genome-wide association studies. | Pabalan N et al. | — | 2021 | → |
| A systems omics-based approach to decode substance use disorders and neuroadaptations. | Veerappa A et al. | — | 2021 | → |
| Selective breeding for high alcohol preference is associated with increased sensitivity to cannabinoid reward within the nucleus accumbens shell. | Hauser SR et al. | — | 2020 | → |
| Pharmacogenetics of Cannabinoids. | Hryhorowicz S et al. | — | 2018 | → |
| CNR1 variation is associated with the age at onset in Huntington disease. | Kloster E et al. | — | 2013 | → |
| Further evidence for association of polymorphisms in the CNR1 gene with cocaine addiction: confirmation in an independent sample and meta-analysis. | Clarke TK et al. | — | 2013 | → |
| The genetic basis of the endocannabinoid system and drug addiction in humans. | López-Moreno JA et al. | — | 2012 | → |
| Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia. | Ho BC et al. | — | 2011 | → |
| CNR1 gene polymorphisms in addictive disorders: a systematic review and a meta-analysis. | Benyamina A et al. | — | 2011 | → |
| Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors. | Serrano A et al. | — | 2011 | → |
| Neurochemical basis of cannabis addiction. | Maldonado R et al. | — | 2011 | → |
| Association of polymorphisms of the cannabinoid receptor (CNR1) and fatty acid amide hydrolase (FAAH) genes with heroin addiction: impact of long repeats of CNR1. | Proudnikov D et al. | — | 2010 | → |
| Candidate genes for cannabis use disorders: findings, challenges and directions. | Agrawal A et al. | — | 2009 | → |
| Cannabinoid receptors in brain: pharmacogenetics, neuropharmacology, neurotoxicology, and potential therapeutic applications. | Onaivi ES | — | 2009 | → |
| Evidence for association between polymorphisms in the cannabinoid receptor 1 (CNR1) gene and cannabis dependence. | Agrawal A et al. | — | 2009 | → |
| Interaction between two independent CNR1 variants increases risk for cocaine dependence in European Americans: a replication study in family-based sample and population-based sample. | Zuo L et al. | — | 2009 | → |
| Association of the cannabinoid receptor gene (CNR1) with ADHD and post-traumatic stress disorder. | Lu AT et al. | — | 2008 | → |
| CNR1 variation modulates risk for drug and alcohol dependence. | Zuo L et al. | — | 2007 | → |
| Genetic polymorphisms of the endocannabinoid system. | Norrod AG et al. | — | 2007 | → |
| No evidence for an involvement of variants in the cannabinoid receptor gene (CNR1) in obesity in German children and adolescents. | Müller TD et al. | — | 2007 | → |
| Association study of the CNR1 gene exon 3 alternative promoter region polymorphisms and substance dependence. | Herman AI et al. | — | 2006 | → |
| Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1). | Barrero FJ et al. | — | 2005 | → |
| Altered cannabinoid receptor mRNA expression in peripheral blood mononuclear cells from marijuana smokers. | Nong L et al. | — | 2002 | → |
| A missense mutation in human fatty acid amide hydrolase associated with problem drug use. | Sipe JC et al. | — | 2002 | → |